REDWOOD CITY, Calif., Dec. 20, 2018 (GLOBE NEWSWIRE) — Guardant Health, Inc. (Nasdaq:GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today announced the … Continue reading